Loading...
You are here:  Home  >  News  >  Business  >  Current Article

Q-State Biosciences to Present Research on ASO Design Technology and Therapeutic Development at Two Upcoming Scientific Conferences

By   /  September 21, 2021  /  Comments Off on Q-State Biosciences to Present Research on ASO Design Technology and Therapeutic Development at Two Upcoming Scientific Conferences

    Print       Email


CAMBRIDGE, Mass.–()–Q-State Biosciences (“Q-State”), a discovery technology and therapeutics company advancing programs for the treatment of epilepsy, pain and other disorders of the central nervous system, today announced two upcoming oral presentations.

On September 23, 2021 at TIDES USA: Oligonucleotide & Peptide Therapeutics taking place in Boston and virtually, Chief Scientific Officer Graham Dempsey, Ph.D. will highlight the company’s novel quantitative de-risking platform for identifying and characterizing neurotoxicity as well as assessing efficacy in candidate antisense oligonucleotide therapeutics.

On September 24, 2021 at Genetic Epilepsies and Other Neuronal Ion Channel Disorders: Mechanisms…



Click here to view the original article.

    Print       Email

You might also like...

Recession warning: BoE official predicts 2008-level economic crash due to Bitcoin & crypto

Read More →